Atlas Trials

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Clinical trial NCT05669677 · COMPLETED

Trial details

NCT number
NCT05669677
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis DNAFLDNASH
Start date
2023-03-15
Primary completion
2025-04-04
Enrollment
233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.